Background and aim: The management of pituitary adenomas secreting TSH has evolved
considerably over the last decades. We report the clinical features, management, and …

Thyrotropin (TSH)-secreting pituitary adenomas account for less than 1% of all pituitary
tumors. In the last two decades, their clinical management has changed markedly due to …

Object The aim of this study was to analyze clinicopathological characteristics and treatment
outcomes in a large single-center clinical series of cases of thyrotropin (TSH)–secreting …

Objective Our aim was to report the recent changes in diagnosis and management of TSH-
secreting pituitary adenomas. Methods We retrieved 43 consecutive patients with TSH …

Purpose TSH-secreting pituitary adenomas are among the less prevalent pituitary tumors,
corresponding to 0.9–1.5% of all pituitary adenomas in surgical series. Methods A series of …

Objective TSH-secreting pituitary tumors (TSH-omas) are a rare cause of hyperthyroidism
and account for< 1% of all pituitary adenomas. Failure to recognize the presence of a TSH …

The reported cases of hyperthyroidism due to a TSH-secreting pituitary adenoma have
steadily increased in previous years; however, information about the results and long term …

Thyrotropin (TSH)-secreting pituitary adenomas represent about 1–2% of all pituitary
adenomas and cause secondary or central hyperthyroidism. TSH-secreting adenomas are …

Objective: Our objective was to describe the effects of surgery and radiotherapy on hormonal
control and tumor mass in short-and long-term follow-up of TSH-secreting pituitary …

Objective TSH‐secreting pituitary adenomas (TSH‐omas) are a rare cause of thyrotoxicosis.
First‐line therapy for these tumours is neurosurgery, although medical therapy with …